Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
September 22, 2026 by reason.org
Youth vaping has collapsed, but lawmakers want $500 million to fight it anyway
Half a billion dollars to fight a collapsing trend deserves scrutiny. Youth vaping has fallen sharply, yet lawmakers are still treating it as an expanding emergency while adult smoking remains the bigger driver of preventable disease. Resources should follow the scale of harm, not the politics of alarm. Serious nicotine policy would protect young people without using outdated crisis language to justify measures that may also make quitting harder for adults.
September 22, 2026 by thejournal.ie
FactFind: Are vapes 'nearly worse' than cigarettes?
The phrase “vaping is worse than smoking” does more than misstate the evidence — it changes behaviour. A smoker who believes that message may see little reason to switch, even though cigarettes remain the far more harmful product. Good fact-checking restores the missing hierarchy: vaping is not harmless, but it is not smoking. Clear risk communication can be the difference between staying with combustion and taking a less harmful route away from it.
September 21, 2026 by regulatorwatch.com
Science Inside | NicoLeaks Supercharges Nicotine Pouch Testing | RegWatch
Nicotine pouch testing should be driven by science, not suspicion by category. Better data on ingredients, emissions, exposure and product performance can help regulators distinguish between responsible smoke-free products and those that fail basic standards. That matters because credible harm reduction depends on transparency as much as access. The stronger the testing framework, the harder it becomes to dismiss pouches with fear — or to defend products that do not meet the evidence.
September 21, 2026 by desmoinesregister.com
FDA finally embraces harm reduction, sees role for vaping | Opinion
Tobacco control embracing harm reduction would mark a shift from fighting nicotine use in the abstract to reducing the harms that actually kill. FDA vaping policy should recognise that adult smokers need legal, evidence-based alternatives capable of moving them away from combustion. That does not weaken prevention or youth protection; it makes the overall strategy more realistic. Public health progress depends on helping people stop smoking, not on treating every nicotine product as the same threat.
September 18, 2026 by linknky.com
Opinion: From habit to health – new paths forward for veterans who smoke
Veterans who smoke need support that recognises habit, stress, trauma and dependence rather than reducing quitting to willpower. Many have tried to stop before, and some may need lower-risk nicotine options that meet them where they are. Harm reduction can create a more realistic path from habit to health by reducing exposure to combustion while keeping people engaged in care. Better cessation support should be practical, respectful and tailored to the lives of those it aims to help.
September 18, 2026 by substack.com
Would Charles Schulz Have Done It This Way?
Pop culture can reveal how much the nicotine debate has changed. A question framed through Charles Schulz and familiar comic-strip nostalgia points to something bigger: public attitudes are shaped as much by stories, humour and moral cues as by evidence. That matters for tobacco harm reduction, because safer nicotine products are often judged through cultural discomfort before their risks are properly compared with smoking. Better public health communication should be clear enough to cut through the cartoon version of the debate.
September 14, 2026 by washingtonexaminer.com
Trump’s FDA followed the science on vaping. Politicians are furious
FDA e-cigarette authorisation should be a scientific process, not a political obstacle course. Adult smokers need legal products assessed on evidence, exposure and their potential to reduce harm compared with continued smoking. A system that delays or rejects lower-risk options while cigarettes remain widely available sends the wrong signal. Regulation should protect consumers without allowing politics to decide which routes away from combustion survive.
September 14, 2026 by github.io
How Australia has Lost Control of the Nicotine Market?
Australia’s nicotine policy has become a case study in disinformation with real-world consequences. Smokers are told to quit, yet lower-risk alternatives are restricted, misrepresented or pushed into channels with less oversight. That confusion protects cigarettes more than it protects public health. Evidence-based communication should explain relative risk clearly, support adult switching and stop treating harm reduction as a threat to tobacco control.
September 14, 2026 by substack.com
Why Is Your Patient Still Smoking Cigarettes?
A patient who still smokes is not a failure of character. It may be a sign that the advice, tools or assumptions around quitting are not meeting the reality of dependence. Clinicians can make a difference by asking what has already been tried, what keeps the cigarette in place, and whether lower-risk nicotine options could support a move away from combustion. Smoking cessation works better when care starts with the person, not the expectation that one method should work for everyone.
September 14, 2026 by substack.com
Why Is Your Patient Still Smoking Cigarettes?
A patient who still smokes is not a failure of character. It may be a sign that the advice, tools or assumptions around quitting are not meeting the reality of dependence. Clinicians can make a difference by asking what has already been tried, what keeps the cigarette in place, and whether lower-risk nicotine options could support a move away from combustion. Smoking cessation works better when care starts with the person, not the expectation that one method should work for everyone.